• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-803-306 Revised 21-Apr-06
Monoclonal Antibody to JAM-C (human) (Gi11)
Add to Clipboard
SYNONYMS anti-Junctional Adhesion Molecule C (human) MAb (Gi11)
anti-JAM-2 (human) (Gi11)
anti-JAM-3 (human) (Gi11)
PRODUCT LINE Cytoskeleton
PRODUCT CATEGORY Immunoglobulin Superfamily Cell Adhesion Molecules [IgSF CAMs] / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-803-306-C050   50 µg 120.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
CLONE: Gi11
ISOTYPE: Mouse IgG1
CONCENTRATION: 1mg/ml
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In buffer containing 0.09% sodium azide.
IMMUNOGEN: Human platelets.
SPECIFICITY: Recognizes human JAM-C  (Junctional Adhesion Molecule C).
APPLICATION: ELISA (1:500)
Flow Cytometry (1:40)
Immunocytochemistry (1:100)
Immunoprecipitation (1:20)
Western Blot (1:200)
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
Product Specific Literature References
The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1: S. Santoso, et al.; J. Exp. Med. 196, 679 (2002) Abstract; Full Text
The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo: T. Chavakis, et al.; J. Biol. Chem. 279, 55602 (2004) Abstract; Full Text
The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions: S. Santoso, et al.; J. Biol. Chem. 280, 36326 (2005) Abstract; Full Text
The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment: T. Keiper, et al.; FASEB J. 19, 2078 (2005) Abstract
Further Categories Containing This Product:
Tight Junctions / Related ProductsMonoclonal Antibodies
 
 

Your items will be kept only for the duration of your visit.